Exjade
deferasirox
This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed only for you or your child. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side
effects not listed in this leaflet. See section 4.
What EXJADE is and what it is used for
What you need to know before you take EXJADE
How to take EXJADE
Possible side effects
How to store EXJADE
Contents of the pack and other information
EXJADE contains an active substance called deferasirox. It is an iron chelator which is a medicine used to remove the excess iron from the body (also called iron overload). It traps and removes excess
iron which is then excreted mainly in the stools.
Repeated blood transfusions may be necessary in patients with various types of anaemia (for example thalassaemia, sickle cell disease or myelodysplastic syndromes (MDS)). However, repeated blood
transfusions can cause a build-up of excess iron. This is because blood contains iron and your body does not have a natural way to remove the excess iron you get with your blood transfusions. In patients with non-transfusion-dependent thalassaemia syndromes, iron overload may also develop over
time, mainly due to increased absorption of dietary iron in response to low blood cell counts. Over time, the excess iron can damage important organs such as the liver and heart. Medicines called iron
chelators are used to remove the excess iron and reduce the risk of it causing organ damage.
EXJADE is used to treat chronic iron overload caused by frequent blood transfusions in patients with beta thalassaemia major aged 6 years and older.
EXJADE is also used to treat chronic iron overload when deferoxamine therapy is contraindicated or inadequate in patients with beta thalassaemia major with iron overload caused by infrequent blood transfusions, in patients with other types of anaemias, and in children aged 2 to 5 years.
EXJADE is also used when deferoxamine therapy is contraindicated or inadequate to treat patients aged 10 years or older who have iron overload associated with their thalassaemia syndromes, but who are not transfusion dependent.
if you are allergic to deferasirox or any of the other ingredients of this medicine (listed in section 6). If this applies to you, tell your doctor before taking EXJADE. If you think you may be allergic, ask your doctor for advice.
if you have moderate or severe kidney disease.
if you are currently taking any other iron chelator medicines.
if you are at an advanced stage of myelodysplastic syndrome (MDS; decreased production of
blood cells by the bone marrow) or have advanced cancer.
Talk to your doctor or pharmacist before taking EXJADE:
if you have a kidney or liver problem.
if you have a cardiac problem due to iron overload.
if you notice a marked decrease in your urine output (sign of kidney problem).
if you develop a severe rash, or difficulty breathing and dizziness or swelling mainly of the face and throat (signs of severe allergic reaction, see also section 4 “Possible side effects”).
if you experience a combination of any of the following symptoms: rash, red skin, blistering of
the lips, eyes or mouth, skin peeling, high fever, flu-like symptoms, enlarged lymph nodes (signs of severe skin reaction, see also section 4 “Possible side effects”).
if you experience a combination of drowsiness, upper right abdominal pain, yellowing or increased yellowing of your skin or eyes and dark urine (signs of liver problems).
if you experience difficulty thinking, remembering information, or solving problems, being less alert or aware or feeling very sleepy with low energy (signs of a high level of ammonia in your blood, which may be associated with liver or renal problems, see also section 4 “Possible side
effects”).
if you vomit blood and/or have black stools.
if you experience frequent abdominal pain, particularly after eating or taking EXJADE.
if you experience frequent heartburn.
if you have a low level of platelets or white blood cells in your blood test.
if you have blurred vision
if you have diarrhoea or vomiting.
If any of these apply to you, tell your doctor straight away.
You will have regular blood and urine tests during treatment. These will monitor the amount of iron in your body (blood level of ferritin) to see how well EXJADE is working. The tests will also monitor
your kidney function (blood level of creatinine, presence of protein in the urine) and liver function (blood level of transaminases). Your doctor may require you to undergo a kidney biopsy, if he/she suspects significant kidney damage. You may also have MRI (magnetic resonance imaging) tests to
determine the amount of iron in your liver. Your doctor will take these tests into consideration when deciding on the dose of EXJADE most suitable for you and will also use these tests to decide when
you should stop taking EXJADE.
Your eyesight and hearing will be tested each year during treatment as a precautionary measure.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes in particular:
other iron chelators, which must not be taken with EXJADE,
antacids (medicines used to treat heartburn) containing aluminium, which should not be taken at the same time of day as EXJADE,
ciclosporin (used to prevent the body rejecting a transplanted organ or for other conditions, such
as rheumatoid arthritis or atopic dermatitis),
simvastatin (used to lower cholesterol),
certain painkillers or anti-inflammatory medicines (e.g. aspirin, ibuprofen, corticosteroids),
oral bisphosphonates (used to treat osteoporosis),
anticoagulant medicines (used to prevent or treat blood clotting),
hormonal contraceptive agents (birth control medicines),
bepridil, ergotamine (used for heart problems and migraines),
repaglinide (used to treat diabetes),
rifampicin (used to treat tuberculosis),
phenytoin, phenobarbital, carbamazepine (used to treat epilepsy),
ritonavir (used in the treatment of HIV infection),
paclitaxel (used in cancer treatment),
theophylline (used to treat respiratory diseases such as asthma),
clozapine (used to treat psychiatric disorders such as schizophrenia),
tizanidine (used as a muscle relaxant),
cholestyramine (used to lower cholesterol levels in the blood),
busulfan (used as a treatment prior to transplantation in order to destroy the original bone marrow before the transplant),
midazolam (used to relieve anxiety and/or trouble sleeping).
Additional tests may be required to monitor the blood levels of some of these medicines.
EXJADE can be used by people aged 65 years and over at the same dose as for other adults. Elderly patients may experience more side effects (in particular diarrhoea) than younger patients. They should
be monitored closely by their doctor for side effects that may require a dose adjustment.
EXJADE can be used in children and adolescents receiving regular blood transfusions aged 2 years and over and in children and adolescents not receiving regular blood transfusions aged 10 years and
over. As the patient grows the doctor will adjust the dose.
EXJADE is not recommended for children aged under 2 years.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
EXJADE is not recommended during pregnancy unless clearly necessary.
If you are currently using a hormonal contraceptive to prevent pregnancy, you should use an additional or different type of contraception (e.g. condom), as EXJADE may reduce the effectiveness of hormonal contraceptives.
Breast-feeding is not recommended during treatment with EXJADE.
If you feel dizzy after taking EXJADE, do not drive or operate any tools or machines until you are feeling normal again.
This medicine contains less than 1 mmol sodium (23 mg) per film-coated tablet, that is to say essentially ‘sodium free’.
Treatment with EXJADE will be overseen by a doctor who is experienced in the treatment of iron overload caused by blood transfusions.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The dose of EXJADE is related to body weight for all patients. Your doctor will calculate the dose you
need and tell you how many tablets to take each day.
The usual daily dose for EXJADE film-coated tablets at the start of the treatment for patients receiving regular blood transfusions is 14 mg per kilogram body weight. A higher or lower starting dose may be recommended by your doctor based on your individual treatment needs.
The usual daily dose for EXJADE film-coated tablets at the start of the treatment for patients not receiving regular blood transfusions is 7 mg per kilogram body weight.
Depending on how you respond to treatment, your doctor may later adjust your treatment to a higher or lower dose.
The maximum recommended daily dose for EXJADE film-coated tablets is:
28 mg per kilogram body weight for patients receiving regular blood transfusions,
14 mg per kilogram body weight for adult patients not receiving regular blood transfusions,
7 mg per kilogram body weight for children and adolescents not receiving regular blood transfusions.
Deferasirox also comes as “dispersible” tablets as generic alternatives. If you are switching from the dispersible tablets to these film-coated tablets, you will need an adjustment of the dose.
Take EXJADE once a day, every day, at about the same time each day with some water.
Take EXJADE film-coated tablets either on an empty stomach or with a light meal.
Taking EXJADE at the same time each day will also help you remember when to take your tablets.
For patients who are unable to swallow whole tablets, EXJADE film-coated tablets may be crushed and taken by sprinkling the full dose onto soft food such as yogurt or apple sauce (pureed apple). The food should be immediately and completely consumed. Do not store it for future use.
check that the treatment is having the desired effect (see also section 2: “Monitoring your EXJADE treatment”).
If you have questions about how long to take EXJADE, talk to your doctor.
If you have taken too much EXJADE, or if someone else accidentally takes your tablets, contact your
doctor or hospital for advice straight away. Show the doctor the pack of tablets. Urgent medical treatment may be necessary. You may experience effects such as abdominal pain, diarrhoea, nausea and vomiting and kidney or liver problems that can be serious.
If you miss a dose, take it as soon as you remember on that day. Take your next dose as scheduled. Do not take a double dose on the next day to make up for the forgotten tablet(s).
Do not stop taking EXJADE unless your doctor tells you to. If you stop taking it, the excess iron will no longer be removed from your body (see also above section “How long to take EXJADE”).
Like all medicines, this medicine can cause side effects, although not everybody gets them. Most of the side effects are mild to moderate and will generally disappear after a few days to a few weeks of treatment.
These side effects are uncommon (may affect up to 1 in 100 people) or rare (may affect up to 1 in
1,000 people).
If you get a severe rash, or difficulty breathing and dizziness or swelling mainly of the face and throat (signs of severe allergic reaction),
If you experience a combination of any of the following symptoms: rash, red skin, blistering of the lips, eyes or mouth, skin peeling, high fever, flu-like symptoms, enlarged lymph nodes,
(signs of severe skin reactions),
If you notice a marked decrease in your urine output (sign of kidney problem),
If you experience a combination of drowsiness, upper right abdominal pain, yellowing or increased yellowing of your skin or eyes and dark urine (signs of liver problems),
If you experience difficulty thinking, remembering information, or solving problems, being less alert or aware or feeling very sleepy with low energy (signs of a high level of ammonia in your
blood, which may be associated with liver or renal problems and lead to a change in your brain function),
If you vomit blood and/or have black stools,
If you experience frequent abdominal pain, particularly after eating or taking EXJADE,
If you experience frequent heartburn,
If you experience partial loss of vision,
If you experience severe upper stomach pain (pancreatitis),
These side effects are uncommon.
If you get blurred or cloudy eyesight,
If you get reduced hearing,
Very common (may affect more than 1 in 10 people)
Disturbance in kidney function tests.
Common (may affect up to 1 in 10 people)
Gastrointestinal disorders, such as nausea, vomiting, diarrhoea, pain in the abdomen, bloating, constipation, indigestion
Rash
Headache
Disturbance in liver function tests
Itching
Disturbance in urine test (protein in the urine) If any of these affects you severely, tell your doctor.
Uncommon (may affect up to 1 in 100 people)
Dizziness
Fever
Sore throat
Swelling of arms or legs
Change in the colour of the skin
Anxiety
Sleep disorder
Tiredness
If any of these affects you severely, tell your doctor.
A decrease in the number of cells involved in blood clotting (thrombocytopenia), in the number of red blood cells (anaemia aggravated), in the number of white blood cells (neutropenia) or in the number of all kinds of blood cells (pancytopenia)
Hair loss
Kidney stones
Low urine output
Tear in stomach or intestine wall that can be painful and cause nausea
Severe upper stomach pain (pancreatitis)
Abnormal level of acid in blood
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects
not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of
this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and the carton after EXP. The expiry date refers to the last day of that month.
Do not use any pack that is damaged or shows signs of tampering.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is deferasirox.
Each film-coated tablet of EXJADE 90 mg contains 90 mg deferasirox.
Each film-coated tablet of EXJADE 180 mg contains 180 mg deferasirox.
Each film-coated tablet of EXJADE 360 mg contains 360 mg deferasirox.
The other ingredients are microcrystalline cellulose; crospovidone; povidone; magnesium stearate; colloidal anhydrous silica and poloxamer. The tablet coating material contains: hypromellose; titanium
dioxide (E171); macrogol (4000); talc; indigo carmine aluminium lake (E132).
EXJADE is supplied as film-coated tablets. The film-coated tablets are ovaloid and biconvex.
EXJADE 90 mg film-coated tablets are light blue and stamped “90” on one side and “NVR” on the other.
EXJADE 180 mg film-coated tablets are medium blue and stamped “180” on one side and “NVR” on the other.
EXJADE 360 mg film-coated tablets are dark blue and stamped “360” on one side and “NVR” on the other.
Each blister pack contains 30 or 90 film-coated tablets. The multipacks contain 300 (10 packs of 30) film-coated tablets.
Not all pack sizes or strengths may be available in your country.
Novartis Europharm Limited
Vista Building
Elm Park, Merrion Road Dublin 4
Ireland
D-90429 Nuremberg Germany
Novartis Farmacéutica SA Ronda de Santa Maria 158
08210 Barberà del Vallès, Barcelona Spain
Sandoz S.R.L. | |||
Str. Livezeni nr. 7A | |||
540472 Targu Mures | |||
Romania | |||
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
SIA Novartis Baltics Lietuvos filialas Tel: +370 5 269 16 50
Novartis Bulgaria EOOD Тел.: +359 2 489 98 28
Novartis s.r.o.
Tel: +420 225 775 111
Novartis Healthcare A/S
Tlf: +45 39 16 84 00
Novartis Pharma Services Inc.
Tel: +356 2122 2872
Novartis Pharma GmbH Tel: +49 911 273 0
Novartis Pharma B.V. Tel: +31 88 04 52 555
SIA Novartis Baltics Eesti filiaal Tel: +372 66 30 810
Novartis Norge AS Tlf: +47 23 05 20 00
Novartis (Hellas) A.E.B.E.
Τηλ: +30 210 281 17 12
Novartis Pharma GmbH
Tel: +43 1 86 6570
Novartis Farmacéutica, S.A. Tel: +34 93 306 42 00
Novartis Poland Sp. z o.o. Tel.: +48 22 375 4888
Novartis Pharma S.A.S.
Tél: +33 1 55 47 66 00
Novartis Farma - Produtos Farmacêuticos, S.A.
Tel: +351 21 000 8600
Novartis Hrvatska d.o.o. Tel. +385 1 6274 220
Novartis Pharma Services Romania SRL
Tel: +40 21 31299 01
Novartis Ireland Limited
Tel: +353 1 260 12 55
Novartis Pharma Services Inc.
Tel: +386 1 300 75 50
Vistor hf.
Sími: +354 535 7000
Novartis Farma S.p.A. Tel: +39 02 96 54 1
Novartis Finland Oy
Puh/Tel: +358 (0)10 6133 200
Novartis Pharma Services Inc.
Τηλ: +357 22 690 690
Novartis Sverige AB
Tel: +46 8 732 32 00
SIA Novartis Baltics
Tel: +371 67 887 070
Novartis Ireland Limited
Tel: +44 1276 698370